FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/01/2021 |
3. Issuer Name and Ticker or Trading Symbol
PEGASYSTEMS INC [ PEGA ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common stock | 46,909 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Restricted Stock Units(1) | 03/02/2018(2) | (3) | Common stock | 1,478 | 0.0 | D | |
Restricted Stock Units(1) | 03/05/2019(4) | (3) | Common stock | 2,728 | 0.0 | D | |
Restricted Stock Units(1) | 03/06/2020(5) | (3) | Common stock | 3,981 | 0.0 | D | |
Restricted Stock Units(1) | 03/03/2021(6) | (3) | Common stock | 5,350 | 0.0 | D | |
Restricted Stock Units(1) | 03/02/2022(7) | (3) | Common stock | 1,125 | 0.0 | D | |
Restricted Stock Units(1) | 03/02/2022(8) | (3) | Common stock | 4,611 | 0.0 | D | |
Stock Options | 03/09/2017(9) | 03/09/2026 | Common stock | 6,177 | 25.2 | D | |
Stock Options | 03/02/2018(10) | 03/02/2027 | Common stock | 15,534 | 44.3 | D | |
Stock Options | 03/05/2019(11) | 03/05/2028 | Common stock | 21,954 | 58.95 | D | |
Stock Options | 03/06/2020(12) | 03/06/2029 | Common stock | 22,595 | 64.35 | D | |
Stock Options | 03/03/2021(13) | 03/03/2030 | Common stock | 26,502 | 90.05 | D | |
Stock Options | 03/02/2022(14) | 03/02/2031 | Common stock | 15,772 | 130.45 | D |
Explanation of Responses: |
1. Each restricted stock unit represents the right to receive, following vesting, one share of the issuer's common stock. |
2. The original grant was 7,387 restricted stock units, with 20% vesting on March 2, 2018, and the remaining 80% vesting in equal quarterly installments over the remaining four years. |
3. Once vested, the shares of common stock are not subject to expiration. |
4. The original grant was 6,819 restricted stock units, with 20% vesting on March 5, 2019, and the remaining 80% vesting in equal quarterly installments over the remaining four years. |
5. The original grant was 6,635 restricted stock units, with 20% vesting on March 6, 2020, and the remaining 80% vesting in equal quarterly installments over the remaining four years. |
6. The original grant was 6,687 restricted stock units, with 20% vesting on March 3, 2021, and the remaining 80% vesting in equal quarterly installments over the remaining four years. |
7. Represents election by the individual, as part of the Company's Corporate Incentive Plan (CICP), to receive half of their annual bonus in RSUs, based upon the Company's stock price as of March 2, 2021. All RSUs vest 100% on March 2, 2022, subject to attainment of the CICP performance threshold funding for the year ending December 31, 2021. |
8. RSUs will vest 20% on March 2, 2022, with the remaining 80% vesting in equal quarterly installments over the remaining four years. |
9. The original grant was 30,883 options, with 20% vesting on March 9, 2017, with the remaining 80% vesting in equal quarterly amounts over the next four years. |
10. The original grant was 24,382 options, with 20% vesting on March 2, 2018, with the remaining 80% vesting in equal quarterly amounts over the next four years. |
11. Options vested 20% on March 5, 2019, with the remaining 80% vesting in equal quarterly amounts over the next four years. |
12. Options vested 20% on March 6, 2020, with the remaining 80% vesting in equal quarterly amounts over the next four years. |
13. Options vested 20% on March 3, 2021, with the remaining 80% vesting in equal quarterly amounts over the next four years. |
14. Options will vest 20% on March 2, 2022, with the remaining 80% vesting in equal quarterly installments over the remaining four years. |
Remarks: |
Rifat Kerim Akgonul became Pegasystems Inc.'s Chief Product Officer effective April 1, 2021. EXHIBIT LIST: EX-24 RKAkgonul Ex. 24 |
/s/ Donald L. Lancaster, Attorney-in-Fact for Rifat Kerim Akgonul | 04/07/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |